Chemotherapy Devices Market is Expected to Grow with a CAGR of 7.5% from 2022 to 2028

Chemotherapy Devices
  • Chemotherapy Devices Market

As stated in our extensive report, providing insights on Product Type, and Application; theGlobalChemotherapy Devices Marketaccounted forUSD 11.54 Billionin 2021.

Cancer is a disease that is affected due to the emergence of abnormal & uncontrollable cell growth in the human body. It is one of the most chronic and fatal diseases that spread to other parts of the body. Thus, chemotherapy is the most frequently prescribed treatment for cancer patients. In order to treat cancer patients, a combination of anti-cancer agents also called chemotherapeutic agents is used. Alkylating agents (tetrazzini, cisplatin), anti-metabolites (pyrimidine, purines), anti-microtubule agents, and cytotoxic agents are some of the examples of chemotherapeutic agents. Various devices are used to administer chemotherapeutic agents and based on the cancer type, these devices are chosen. Chemotherapeutic drugs are given to patients through intravenous injections.

Some of the major factors that influence the growth of Chemotherapy Devices Market over projected time span is raising public awareness, improved healthcare infrastructure, growing incidence & prevalence of cancer, increasing funding in the development of new therapies across the globe, and usage of advance technologies in new product development.

According to WHO (World Health Organization), cancer is the major cause of death worldwide. It is estimated that, in 2020, 19.3 million new cancer cases found and around 10.0 million cancer deaths occurred. Thus, in past few years, there is huge progress in cancer care by adopting advanced treatment modalities of surgery. In addition, various market players also contribute to the market growth by launching a new product or by providing strategic development. For instance, BD (Becton, Dickinson, and Company), an American multinational medical technology company, launched a special educational program on chemo ports on world cancer day. These ports are used to deliver chemotherapy to cancer patients. Therefore, all these factors are predicting maximum growth of Chemotherapy Devices Market over a projected time period.

Chemotherapy can cause unpleasant side effects such as tiredness, feeling & being sick, hair loss, anemia, bruising & bleeding, loss of appetite, sore mouth, and many more. This kind of discomfort inpatient is the major obstacle of Chemotherapy Devices Market in the coming years.

North America is accounted for the largest growth of Chemotherapy Devices market during the forecast period. This growth is mainly accounted by the high usage of chemotherapy devices across multiple countries in this region. In addition, the increasing number of cancer patients, improved health care infrastructure, increased government investments, and ongoing projects to develop advanced drugs to treat cancer patients are the major factors that influence the growth of Chemotherapy Devices Market in this region.

Some of the prominent players operating in the Global Chemotherapy Devices MarketareAdvanced Chemotherapy Technologies (US), Baxter International (US), Becton Dickinson (US), B. Braun (Germany), Fresenius Kabi (Germany), Halyard Health (US), ICU Medical (US), Moog Inc (US), Micrel Medical (Sweden), Smiths Group (UK), Terumo Corporation (Japan), and Zyno Medical (US)..